Content about Pfizer

January 18, 2012
Executive Viewpoint Part 1: Engaging consumers on health and wellness

In an effort to tap into the minds of some of the industry's top executives, Drug Store News recently sat down and talked with some of these leaders in a multipart executive viewpoint video series.

May 17, 2012
FDA approves generic versions of Plavix

The Food and Drug Administration has approved generic versions of one of the country's top-selling drugs made by eight different companies, the agency said Thursday.

May 17, 2012
Sagent launches generic chemotherapy drug

Sagent Pharmaceuticals has launched a generic version of a chemotherapy drug, the company said Thursday.

May 16, 2012
Results from phase-3 trial of Pfizer cancer drug disappoint

An experimental kidney cancer drug made by Pfizer didn't extend the time in which patients survived without their disease worsening when compared with a competing drug, according to results of a late-stage clinical trial released Wednesday.

May 15, 2012
Reports: Pfizer 'quietly' giving up on Lipitor marketing

Pfizer apparently is relenting on its attempt to drive sales of its top cholesterol drug as several new generic versions look set to enter the market, according to published reports.

May 10, 2012
FDA panel recommends approval for Pfizer RA drug

A Food and Drug Administration expert panel has recommended approval for a drug made by Pfizer for treating rheumatoid arthritis.

May 4, 2012
Armada summit's growth in attendance symbolizes growth of specialty channel

A 30% rise in attendance at the Armada Specialty Pharmacy Summit is nothing to brush off — it's as clear an indication as any that specialty pharmacy is growing and probably poised for more growth in the near future, thanks in particular to the aging population and consequential rise in the number of people living with difficult-to-treat medical conditions.

May 3, 2012
Orphan drugs to see growth through 2018, report finds

Drug makers could strike big with new treatments for rare diseases, according to a new report by a market research firm.

May 2, 2012
FDA approves Pfizer, Protalix drug for Gaucher disease

The Food and Drug Administration has approved a new treatment for a rare genetic disorder that affects 10,000 people worldwide.

April 27, 2012
Mylan, Pfizer, Teva reach deal over generic version of EpiPen

Two companies have settled with Teva over the latter's efforts to launch a generic version of an emergency treatment for allergic reactions.

April 23, 2012
Pfizer sells nutrition business to Nestlé

Pfizer is selling its nutrition business to Nestle for $11.85 billion, Pfizer said Monday.

April 20, 2012
Advil Congestion Relief Project relieves community congestion at site No. 2

As part of a nationwide effort to help communities fight congestion, Pfizer Consumer Healthcare is partnering with the Ohio Association of Police Athletic & Activities League to create more space for the local mentorship program.

April 20, 2012
Genzyme to present MS drug trials

Drug maker Genzyme plans to present data from trial programs of two multiple sclerosis drugs at the American Academy of Neurology's annual meeting in New Orleans, which starts this Saturday and lasts until next Saturday.

April 13, 2012
Lilly chief executive John Lechleiter appointed as PhRMA chairman

The Pharmaceutical Research and Manufacturers of America announced Friday the appointment of Eli Lilly chairman, president and CEO John Lechleiter as PhRMA chairman at its annual meeting.

April 12, 2012
Pfizer Consumer Healthcare to refurbish after-school trolley in Albany, N.Y.

Pfizer Consumer Healthcare on Wednesday partnered with an Albany, N.Y. organization, the CURE Foundation, to refurbish a trolley to be used to shuttle area youth to and from after-school activities.

April 11, 2012
Reports: Humira to become top-selling drug this year

Move over, Lipitor: There's a new top drug on the market, according to published reports.

April 9, 2012
Pfizer brings Lipitor marketing campaign to Walgreens Chicago flagship store

Drug maker Pfizer is taking a marketing campaign for one of its drugs to Walgreens' Chicago flagship store to raise awareness about high cholesterol and healthy eating, the company said Monday.

March 29, 2012
Kline unveils 2011 drivers of U.S. OTC market

The U.S. over-the-counter drug market saw strong growth in 2011, thanks to switches of prescription drugs to OTC, gains in the allergy relief products category and holistic marketing, according to a new report from Kline.

March 26, 2012
Suppliers, FDA shine spotlight on switches

The recent Food and Drug Administration public meeting on driving future switch potential by way of the pharmacist and/or health technology sparked some discussion on what’s next.


March 13, 2012
Pfizer, Biocon end biosimilar insulin deal

Pfizer and Indian drug maker Biocon have ended a partnership that the companies started in 2010 to develop biosimilar treatments for diabetes, the companies said.

March 9, 2012
Pat Lonergan honored with CHPA Lifetime Achievement Award

The Consumer Healthcare Products Association on Friday morning honored longtime industry veteran Pat Lonergan, co-founder of Numark Labs, with its Ivan D. Combe Lifetime Achievement Award for his contributions in the advancement of the business of over-the-counter medicines.

March 6, 2012
FDA declines to approve Merck cholesterol drug

The Food and Drug Administration is asking for additional data before it approves a new cholesterol drug made by Merck, the drug maker said.

March 5, 2012
Dr. Reddy's launches generic version of Pfizer's Geodon

Indian drug maker Dr. Reddy's has launched a drug designed to treat bipolar disorder and schizophrenia, the company said.

February 21, 2012
Nearly $1 billion in damages asserted in lawsuit over GERD drug

A division of Pfizer is asserting that it incurred nearly $1 billion in damages related to the launch of generic versions of one of its drugs.

February 21, 2012
Pfizer inks generics deal with Chinese drug maker

Pfizer has signed a deal worth more than $500 million with a Chinese drug maker to make generic drugs for China and other markets, the companies said.

© 2012 Drug Store News. All Rights Reserved.